Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion
Arnold H. Zea, Paulo C. Rodrı́guez, Michael B. Atkins et al. · Cancer Research · 2005
Myeloid suppressor cells with high arginase activity are found in tumors and spleen of mice with colon and lung cancer. These cells, described as macrophages or immature dendritic cells, deplete arginine and impair T cell proliferation and cytokine production. Although arginase activity has been described in cancer patients, it is thought to originate from tumor cells metabolizing arginine to ornithine needed to sustain rapid cell proliferation. The goal of this study was to determine whether myeloid suppressor cells producing high arginase existed in renal cell carcinoma patients. Peripheral blood mononuclear cells from 123 patients with metastatic renal cell carcinoma, prior to treatment, were found to have a significantly increased arginase activity. These patients had a markedly decreased cytokine production and expressed low levels of T cell receptor CD3zeta chain. Cell separation studies showed that the increased arginase activity was limited to a specific subset of CD11b+, CD14-, CD15+ cells with a polymorphonuclear granulocyte morphology and markers, instead of macrophages or dendritic cells described in mouse models. Furthermore, these patients had low levels of arginine and high levels of ornithine in plasma. Depletion of the CD11b+, CD14- myeloid suppressor cells reestablished T cell proliferation and CD3zeta chain expression. These results showed, for the first time, the existence of suppressor myeloid cells producing arginase in human cancer patients. In addition, it supports the concept that blocking arginase may be an important step in the success of immunotherapy.
Cited by 851 works. doi:10.1158/0008-5472.can-04-4505
Authors
- Arnold H. Zea
- Paulo C. Rodrı́guez
- Michael B. Atkins
- Claudia Hernandez
- Sabina Signoretti
- Jovanny Zabaleta
- David F. McDermott
- David G. Quiceno
- Amanda J. Youmans
- Anne O’Neill
- James Walter Mier
- Augusto C. Ochoa
References
- Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma
- Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.
- Mechanisms and functional significance of tumour-induced dendritic-cell defects
- Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses
- IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice
- L-arginine metabolism in myeloid cells controls T-lymphocyte functions
- l -Arginine Consumption by Macrophages Modulates the Expression of CD3ζ Chain in T Lymphocytes
- Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.
- Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity
- Immortalized Myeloid Suppressor Cells Trigger Apoptosis in Antigen-Activated T Lymphocytes